Form D · Venture Capital Fund

Decheng Capital China Life Sciences USD Fund I, L.P.

Grand Cayman, E9 · CIK 0001537339

Offering snapshot reported Jun 5, 2013 · SEC filing

Reported sold: $123M
Investors reported: 17
Minimum accepted: $0
First sale: Dec 15, 2011

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 17

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 5, 2013	Amendment	$123,001,753	No comparison	17	SEC filing
Dec 15, 2011	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-170136

Source: Form D, filed Jun 5, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND I, L.P.

Investment adviser: DECHENG CAPITAL LLC

Gross asset value: $78.9M
Beneficial owners: 21
ADV minimum commitment: $5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C FUND SERVICES (ASIA) LIMITED HONG KONG, Hong Kong Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor PRICEWATERHOUSECOOPERS LLP SAN FRANCISCO, California, United States

Custodian FIRST-CITIZENS BANK & TRUST COMPANY SANTA CLARA, California, United States Related to adviser: No

Custodian GOLDMAN SACHS & CO. LLC NEW YORK CITY, New York, United States Related to adviser: No

Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK CITY, New York, United States Related to adviser: No

Custodian MORGAN STANLEY SMITH BARNEY LLC PURCHASE, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

FIRST-CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

GOLDMAN SACHS & CO. LLC
SEC 8-129

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

MORGAN STANLEY SMITH BARNEY LLC
SEC 8-68191

Filing source

Form ADV 2071333 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-4235681694

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Decheng Capital China Life Sciences USD Fund I, L.P. (this fund)	Jun 5, 2013	$123,001,753	17
Decheng Capital China Life Sciences USD Fund II, L.P.	Aug 17, 2015	Yet to sell	0
Decheng Capital China Life Sciences USD Fund III, L.P.	Apr 30, 2018	Yet to sell	0

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A N/A Bay City Capital Llc	Director, Promoter
Xiangmin Cui	Director, Promoter
N/A N/A Decheng Capital China Management I (Cayman), Llc	Promoter
N/A N/A Dt Capital Management Company Limited	Director, Promoter
Xiangmin Min	Director, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/O Maples Corporate Services Limited Ugland House, P.O. Box 309
Grand Cayman, E9, KY1-1104